A new weight-loss treatment, Tirzepatide (Mounjaro), is being introduced on the NHS to support individuals living with obesity. It will join the existing range of injectable medications, including Wegovy (semaglutide) and Saxenda (liraglutide). This announcement, alongside media reports that GPs may begin prescribing these treatments from 23 June 2025, has understandably generated a great deal…